Literature DB >> 3477650

Concentration of pefloxacine in split ejaculates of patients with chronic male accessory gland infection.

F H Comhaire1.   

Abstract

The concentrations of pefloxacine and its N-demethylated derivative were measured in split ejaculates of 12 patients with chronic male accessory gland infection during treatment with 400 mg. pefloxacine twice a day. The mean concentrations of pefloxacine and N-demethylated pefloxacine (mg. per l.) were 8.7 +/- 1.2 (standard error of the mean) and 4.2 +/- 0.7 in fraction 1, and 9.8 +/- 1.1 and 4.3 +/- 0.6 in fraction 2. The concentrations in both fractions were correlated strongly (r equals 0.97). The concentration of pefloxacine in the secretory fluids of the prostate and seminal vesicles are 30-fold the minimal inhibitory concentration 90 of Escherichia coli and Klebsiella species, 100-fold the minimal inhibitory concentration 90 of Proteus mirabilis and equal to the minimal inhibitory concentration 90 of Streptococcus faecalis. In three-fourths of the patients signs of infection resolved after 4 weeks of treatment.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3477650     DOI: 10.1016/s0022-5347(17)43386-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  A new method to estimate quantitatively seminal vesicle and prostate gland contributions to ejaculate.

Authors:  Themba T Ndovi; Teresa Parsons; Leena Choi; Brian Caffo; Charles Rohde; Craig W Hendrix
Journal:  Br J Clin Pharmacol       Date:  2006-10-31       Impact factor: 4.335

Review 2.  Quinolones in urology.

Authors:  K T Nielsen; P O Madsen
Journal:  Urol Res       Date:  1989

Review 3.  Drugs in semen.

Authors:  S Pichini; P Zuccaro; R Pacifici
Journal:  Clin Pharmacokinet       Date:  1994-05       Impact factor: 6.447

Review 4.  Pefloxacin clinical pharmacokinetics.

Authors:  F Bressolle; F Gonçalves; A Gouby; M Galtier
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.